Patel Sandip I
CIK 1843601
Transactions on file
9
Open-market buys
2
Win rate (buys)
0%
2 scored
Avg % since filing (buys)
-24.2%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-16 | 2026-10-14 | AKTX Akari Therapeutics Plc | Director | Exer. | 6,186 | $2.47 | +1907400.0% | open → |
| 2026-10-16 | 2026-10-14 | AKTX Akari Therapeutics Plc | Director | Exer. | 3,866 | $1.55 | +1907400.0% | open → |
| 2026-10-16 | 2026-10-05 | AKTX Akari Therapeutics Plc | Director | Grant | 4,313 | $34.1K | -3.4% | open → |
| 2026-10-16 | 2026-08-18 | AKTX Akari Therapeutics Plc | Director | Grant | 12,100 | $95.6K | -3.4% | open → |
| 2026-09-28 | 2026-09-25 | ATCH AtlasClear Holdings, Inc. | OfficerDirector CFO & General Counsel | Buy | 50,000 | $9.9K | -20.6% | open → |
| 2026-09-28 | 2026-09-24 | ATCH AtlasClear Holdings, Inc. | OfficerDirector CFO & General Counsel | Buy | 50,000 | $10.9K | -27.8% | open → |
| 2026-09-28 | 2026-09-25 | ATCH AtlasClear Holdings, Inc. | OfficerDirector CFO & General Counsel | Grant | 50,000 | $9.9K | -20.6% | open → |
| 2026-09-28 | 2026-09-24 | ATCH AtlasClear Holdings, Inc. | OfficerDirector CFO & General Counsel | Grant | 50,000 | $10.9K | -27.8% | open → |
| 2025-04-29 | 2025-03-06 | AKTX Akari Therapeutics Plc | Director | Grant | 44,642 | $50.0K | +581.2% | open → |
